Global Recombinant Collagen-Based Biomaterial Market Research Report 2024

Publication ID:

PB506243520

Publication Date:

June 17, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Recombinant collagen-based biomaterials are collagen produced by biotechnology, usually synthesized in microorganisms or plant cells using recombinant DNA technology. Compared with traditional animal-derived collagen, recombinant collagen has higher purity and consistency, does not contain animal pathogens, and reduces the risk of immune response. It is widely used in the fields of medicine, pharmaceuticals, cosmetics, food and bioprinting, providing excellent biocompatibility and functional diversity, and promoting the development of tissue repair, wound healing, skin care and anti-aging, nutritional supplements and tissue engineering.
The global Recombinant Collagen-Based Biomaterial market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Recombinant collagen-based biomaterials are produced through biotechnology, with advantages such as high purity, good quality consistency, and no animal pathogens, which greatly reduces the risk of immune response. This material shows broad application prospects in the fields of medicine, pharmaceuticals, cosmetics, food, and bioprinting. In medicine, recombinant collagen is used in tissue engineering and wound repair to promote tissue regeneration and healing; in the cosmetic field, it has become an important ingredient in skin care products due to its excellent moisturizing and anti-aging properties; in food and nutritional supplements, recombinant collagen provides health and beauty benefits and supports joint and skin health. In addition, recombinant collagen is used in 3D bioprinting technology to help build complex biological structures and develop tissue engineering. The versatility and safety of this material make it a key factor in promoting innovation and development in multiple industries.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Collagen-Based Biomaterial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Collagen-Based Biomaterial.
The Recombinant Collagen-Based Biomaterial market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Collagen-Based Biomaterial market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Collagen-Based Biomaterial manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Evonik Industries
Trautec
Genemedicine
FibroGen
CollPlant
Geltor
Modern Meadow
by Type
Medical Grade Recombinant Collagen
Cosmetic Grade Recombinant Collagen
Food Grade Recombinant Collagen
Others
by Application
Medical Industry
Cosmetic Industry
Food Industry
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Collagen-Based Biomaterial manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Recombinant Collagen-Based Biomaterial by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Recombinant Collagen-Based Biomaterial in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Recombinant Collagen-Based Biomaterial Market Overview
1.1 Product Definition
1.2 Recombinant Collagen-Based Biomaterial by Type
1.2.1 Global Recombinant Collagen-Based Biomaterial Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Medical Grade Recombinant Collagen
1.2.3 Cosmetic Grade Recombinant Collagen
1.2.4 Food Grade Recombinant Collagen
1.2.5 Others
1.3 Recombinant Collagen-Based Biomaterial by Application
1.3.1 Global Recombinant Collagen-Based Biomaterial Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Medical Industry
1.3.3 Cosmetic Industry
1.3.4 Food Industry
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Recombinant Collagen-Based Biomaterial Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Recombinant Collagen-Based Biomaterial Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Recombinant Collagen-Based Biomaterial Production Estimates and Forecasts (2019-2030)
1.4.4 Global Recombinant Collagen-Based Biomaterial Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Recombinant Collagen-Based Biomaterial Production Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Collagen-Based Biomaterial Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Recombinant Collagen-Based Biomaterial, Industry Ranking, 2022 VS 2023
2.4 Global Recombinant Collagen-Based Biomaterial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Recombinant Collagen-Based Biomaterial Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Product Offered and Application
2.8 Global Key Manufacturers of Recombinant Collagen-Based Biomaterial, Date of Enter into This Industry
2.9 Recombinant Collagen-Based Biomaterial Market Competitive Situation and Trends
2.9.1 Recombinant Collagen-Based Biomaterial Market Concentration Rate
2.9.2 Global 5 and 10 Largest Recombinant Collagen-Based Biomaterial Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Recombinant Collagen-Based Biomaterial Production by Region
3.1 Global Recombinant Collagen-Based Biomaterial Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Recombinant Collagen-Based Biomaterial Production Value by Region (2019-2030)
3.2.1 Global Recombinant Collagen-Based Biomaterial Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Recombinant Collagen-Based Biomaterial by Region (2025-2030)
3.3 Global Recombinant Collagen-Based Biomaterial Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Recombinant Collagen-Based Biomaterial Production by Region (2019-2030)
3.4.1 Global Recombinant Collagen-Based Biomaterial Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Recombinant Collagen-Based Biomaterial by Region (2025-2030)
3.5 Global Recombinant Collagen-Based Biomaterial Market Price Analysis by Region (2019-2024)
3.6 Global Recombinant Collagen-Based Biomaterial Production and Value, Year-over-Year Growth
3.6.1 North America Recombinant Collagen-Based Biomaterial Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Recombinant Collagen-Based Biomaterial Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Recombinant Collagen-Based Biomaterial Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Recombinant Collagen-Based Biomaterial Production Value Estimates and Forecasts (2019-2030)
4 Recombinant Collagen-Based Biomaterial Consumption by Region
4.1 Global Recombinant Collagen-Based Biomaterial Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Recombinant Collagen-Based Biomaterial Consumption by Region (2019-2030)
4.2.1 Global Recombinant Collagen-Based Biomaterial Consumption by Region (2019-2030)
4.2.2 Global Recombinant Collagen-Based Biomaterial Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Recombinant Collagen-Based Biomaterial Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Recombinant Collagen-Based Biomaterial Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Recombinant Collagen-Based Biomaterial Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Recombinant Collagen-Based Biomaterial Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Recombinant Collagen-Based Biomaterial Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Recombinant Collagen-Based Biomaterial Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Recombinant Collagen-Based Biomaterial Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Recombinant Collagen-Based Biomaterial Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Recombinant Collagen-Based Biomaterial Production by Type (2019-2030)
5.1.1 Global Recombinant Collagen-Based Biomaterial Production by Type (2019-2024)
5.1.2 Global Recombinant Collagen-Based Biomaterial Production by Type (2025-2030)
5.1.3 Global Recombinant Collagen-Based Biomaterial Production Market Share by Type (2019-2030)
5.2 Global Recombinant Collagen-Based Biomaterial Production Value by Type (2019-2030)
5.2.1 Global Recombinant Collagen-Based Biomaterial Production Value by Type (2019-2024)
5.2.2 Global Recombinant Collagen-Based Biomaterial Production Value by Type (2025-2030)
5.2.3 Global Recombinant Collagen-Based Biomaterial Production Value Market Share by Type (2019-2030)
5.3 Global Recombinant Collagen-Based Biomaterial Price by Type (2019-2030)
6 Segment by Application
6.1 Global Recombinant Collagen-Based Biomaterial Production by Application (2019-2030)
6.1.1 Global Recombinant Collagen-Based Biomaterial Production by Application (2019-2024)
6.1.2 Global Recombinant Collagen-Based Biomaterial Production by Application (2025-2030)
6.1.3 Global Recombinant Collagen-Based Biomaterial Production Market Share by Application (2019-2030)
6.2 Global Recombinant Collagen-Based Biomaterial Production Value by Application (2019-2030)
6.2.1 Global Recombinant Collagen-Based Biomaterial Production Value by Application (2019-2024)
6.2.2 Global Recombinant Collagen-Based Biomaterial Production Value by Application (2025-2030)
6.2.3 Global Recombinant Collagen-Based Biomaterial Production Value Market Share by Application (2019-2030)
6.3 Global Recombinant Collagen-Based Biomaterial Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Evonik Industries
7.1.1 Evonik Industries Recombinant Collagen-Based Biomaterial Company Information
7.1.2 Evonik Industries Recombinant Collagen-Based Biomaterial Product Portfolio
7.1.3 Evonik Industries Recombinant Collagen-Based Biomaterial Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Evonik Industries Main Business and Markets Served
7.1.5 Evonik Industries Recent Developments/Updates
7.2 Trautec
7.2.1 Trautec Recombinant Collagen-Based Biomaterial Company Information
7.2.2 Trautec Recombinant Collagen-Based Biomaterial Product Portfolio
7.2.3 Trautec Recombinant Collagen-Based Biomaterial Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Trautec Main Business and Markets Served
7.2.5 Trautec Recent Developments/Updates
7.3 Genemedicine
7.3.1 Genemedicine Recombinant Collagen-Based Biomaterial Company Information
7.3.2 Genemedicine Recombinant Collagen-Based Biomaterial Product Portfolio
7.3.3 Genemedicine Recombinant Collagen-Based Biomaterial Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Genemedicine Main Business and Markets Served
7.3.5 Genemedicine Recent Developments/Updates
7.4 FibroGen
7.4.1 FibroGen Recombinant Collagen-Based Biomaterial Company Information
7.4.2 FibroGen Recombinant Collagen-Based Biomaterial Product Portfolio
7.4.3 FibroGen Recombinant Collagen-Based Biomaterial Production, Value, Price and Gross Margin (2019-2024)
7.4.4 FibroGen Main Business and Markets Served
7.4.5 FibroGen Recent Developments/Updates
7.5 CollPlant
7.5.1 CollPlant Recombinant Collagen-Based Biomaterial Company Information
7.5.2 CollPlant Recombinant Collagen-Based Biomaterial Product Portfolio
7.5.3 CollPlant Recombinant Collagen-Based Biomaterial Production, Value, Price and Gross Margin (2019-2024)
7.5.4 CollPlant Main Business and Markets Served
7.5.5 CollPlant Recent Developments/Updates
7.6 Geltor
7.6.1 Geltor Recombinant Collagen-Based Biomaterial Company Information
7.6.2 Geltor Recombinant Collagen-Based Biomaterial Product Portfolio
7.6.3 Geltor Recombinant Collagen-Based Biomaterial Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Geltor Main Business and Markets Served
7.6.5 Geltor Recent Developments/Updates
7.7 Modern Meadow
7.7.1 Modern Meadow Recombinant Collagen-Based Biomaterial Company Information
7.7.2 Modern Meadow Recombinant Collagen-Based Biomaterial Product Portfolio
7.7.3 Modern Meadow Recombinant Collagen-Based Biomaterial Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Modern Meadow Main Business and Markets Served
7.7.5 Modern Meadow Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Recombinant Collagen-Based Biomaterial Industry Chain Analysis
8.2 Recombinant Collagen-Based Biomaterial Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Recombinant Collagen-Based Biomaterial Production Mode & Process
8.4 Recombinant Collagen-Based Biomaterial Sales and Marketing
8.4.1 Recombinant Collagen-Based Biomaterial Sales Channels
8.4.2 Recombinant Collagen-Based Biomaterial Distributors
8.5 Recombinant Collagen-Based Biomaterial Customers
9 Recombinant Collagen-Based Biomaterial Market Dynamics
9.1 Recombinant Collagen-Based Biomaterial Industry Trends
9.2 Recombinant Collagen-Based Biomaterial Market Drivers
9.3 Recombinant Collagen-Based Biomaterial Market Challenges
9.4 Recombinant Collagen-Based Biomaterial Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Evonik Industries
Trautec
Genemedicine
FibroGen
CollPlant
Geltor
Modern Meadow

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂